Xiaohui Zhang, MD
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology · Peking University People's Hospital · Peking University Insititute of Hematology, Peking University People's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiaohui Zhang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07586813 · Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsPeking University People's Hospital · recruiting · Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal Neoplasms · principal investigator
- Ph2NCT07586826 · Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsPeking University People's Hospital · recruiting · Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers · principal investigator
- N/ANCT07101770 · A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital · recruiting · Aplastic Anemia, Pregnancy, Prediction Model · principal investigator
- N/ANCT06022445 · Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCTPeking University People's Hospital · unknown · Stem Cell Transplant Complications · principal investigator
- Ph2NCT05852847 · Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05446831 · Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · ITP, Immune Thrombocytopenia · principal investigator
- Ph3NCT05438875 · The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9Peking University People's Hospital · completed · Purpura, Thrombocytopenic, Idiopathic · principal investigator
- Ph2NCT05369364 · The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT05369377 · Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph1NCT04518878 · Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Peking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04516837 · Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Peking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04481282 · The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT04368598 · The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPPeking University People's Hospital · unknown · Immune Thrombocytopenia · principal investigator
- Ph2NCT03909763 · Combination of Danazole With Berberine in the Treatment of ITPPeking University People's Hospital · unknown · Corticosteroid-resistant or Relapsed ITP · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.